GENI vs SSTK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

GENI

49.5
AI Score
VS
GENI Wins

SSTK

36.4
AI Score

Investment Advisor Scores

GENI

50score
Recommendation
HOLD

SSTK

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric GENI SSTK Winner
Forward P/E 58.4795 42.1941 SSTK
PEG Ratio 0 2.65 Tie
Revenue Growth 64.7% -16.9% GENI
Earnings Growth 0.0% -26.0% GENI
Tradestie Score 49.5/100 36.4/100 GENI
Profit Margin -23.0% -22.9% SSTK
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL GENI

Relative Price Performance (Last 90 Days)

GENI 1M: -10.8% · 3M: -3.0% SSTK 1M: -10.6% · 3M: -65.2%

Current Technical Phase

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $6.82

SSTK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -33.9%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $5.04

Fundamentals Snapshot

Metric GENI SSTK
Market Cap
Forward P/E 6.4 10.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.6% -0.2%
Gross Margin 0.3% 0.6%
Operating Margin -0.1% 0.1%
EPS -0.64 -5.72
Dividend Yield 0.27%

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.